USPTO trademark

NXERA

Under examinationUSPTOWord markClass 9Class 35Class 42

"NXERA" is a word mark owned by Nxera Pharma Co., Ltd., filed at the USPTO on April 16, 2026. It is under examination and covers classes 9, 35 and 42.

View Nxera Pharma Co., Ltd. portfolioGet this data via the API
Official USPTO record
NXERA trademark as filed
As filed with the USPTO
Status
Under examination
Since August 28, 2026
Filed
April 16, 2026
Registered
Not yet
Priority date
October 17, 2025
Claimed from United Kingdom
Application no.
99767902
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns NXERA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Nxera Pharma Co., Ltd.

Tokyo, Japan

15 trademarks in the portfolioView company

Representative

Eric Lamb

FBT Gibbons LLP

Goods and services

What the mark covers

The products and services NXERA is filed for, grouped by Nice class.

  • Software, application software, computer software, computer software platforms, artificial intelligence, generative artificial intelligence software, generative design software, deep learning software, neural networks software and machine learning software, large language models software, frontier models software, foundation models software, retrieval augmented generation trained models software, knowledge graphs software; computer software for accessing, browsing and searching online databases; computer software for searching, tracking, modelling, exploration and analysis of data; artificial intelligence software for searching, tracking, modelling, exploration and analysis of data; databases; computer databases; data banks; electronic databases; interactive databases; data processing software; all of the aforementioned being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics.

  • Database management; computer database management; collection and compilation of data; compilation and systemisation of information and data in computer databases; compilation of information and data relating to life sciences, chemical and biological drug discovery, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics; data processing, systemisation and management; data processing services; providing business statistical information for use in predictive analytics and predictive modelling via computer databases; information, advisory and consultancy services relating to all of the aforesaid services.

  • design and development of computer software; providing online non-downloadable computer software; providing online non-downloadable computer software for searching, tracking, modelling, exploration and analysis of data; computer programming; compilation of scientific information; preparation of scientific and technological reports; provision of scientific and technical information and data; information, advisory and consultancy services relating to all of the aforesaid services; Artificial intelligence as a service (AIaaS), software as a service, platform as a service (PaaS); all of the aforementioned being in the field of life sciences, chemical and biological drug discovery, molecular simulation, target identification, lead identification, pharmaceuticals, design and development of drugs, diagnostics and therapeutics.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notification of non-final action e-mailed
  2. Non-final action e-mailed
  3. Non-final action written
  4. Assigned to examiner
  5. New application office supplied data entered
  6. Application filing receipt mailed
  7. New application entered
FAQ

About NXERA

Who owns the trademark "NXERA"?

The USPTO trademark "NXERA" (application 99767902) is owned by Nxera Pharma Co., Ltd.

What is the status of "NXERA"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NXERA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019da370-9356-70e8-8089-20bd42eb9798
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019da370-9356-70e8-8089-20bd42eb9798",
  "object": "trademark",
  "mark_text": "NXERA",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99767902",
  "filing_date": "2026-04-16",
  "nice_classes": [
    9,
    35,
    42
  ],
  "owners": [
    {
      "name": "Nxera Pharma Co., Ltd.",
      "entity_id": "ent_019ebaba-1670-77fd-a8ef-7433192214fd"
    }
  ]
}